Singapore markets close in 2 hours 52 minutes

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.0000-0.0300 (-2.91%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0300
Open1.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.9700 - 1.0302
52-week range0.9100 - 2.3200
Volume6,297
Avg. volume12,696
Market cap37.823M
Beta (5Y monthly)0.94
PE ratio (TTM)N/A
EPS (TTM)-0.7600
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • GlobeNewswire

    HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

    MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2024. Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “We reached an imp

  • GlobeNewswire

    HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

    MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023. Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stat

  • Simply Wall St.

    Rebecca Byam Bought 122% More Shares In HCW Biologics

    HCW Biologics Inc. ( NASDAQ:HCWB ) shareholders (or potential shareholders) will be happy to see that the Chief...